Nielsen, JD.com Cooperate on MTA Launch in China
Nielsen, leading global measurement and data analytics company, has announced a strategic cooperation agreement with Chinese e-commerce giant JD.com formalising the collaborative launch of a Multi-Touch Attribution (MTA) offering in China. MTA solutions help marketers assess the sales impact of advertising and marketing investments across media platforms.
As part of this collaboration, Nielsen and JD.com will jointly market the MTA offering to help marketers better determine the effectiveness and return on investment (ROI) of ads both in and outside of JD.com.
Executives of both JD.com and Nielsen unveiled the MTA solutions at the joint forum.
A "first of its kind" solution in China, this joint effort will leverage anonymised data from JD.com's cloud platform and their 236.5 million active users, along with Nielsen's digital media monitoring data and analytics expertise. The joint offering will help advertisers more efficiently allocate advertising and marketing budgets to increase their ROI.
Digital media spend now exceeds that of traditional media, and the increase in digital marketing investments has brought added complexity. Consumers are regularly exposed to multiple media touch points across different devices and platforms during the path to purchase, making it nearly impossible for marketers to comprehensively measure the effectiveness of their investments. Until now, a typical approach for measuring digital marketing performance has been to attribute a sale to the consumer's last advertising exposure or touch point before a purchase. Though this approach might offer insight into the final steps of a consumer's path to purchase, it disregards countless previous touch points throughout the online shopping journey.
"The increased fragmentation of online media has created a landscape where consumers are seeing and clicking on hundreds of touch points before they make a purchase. For brands who are trying to measure and optimise their online marketing ROI, this is a massive problem that previous analytics platforms have been unable to solve effectively," said Vishal Bali, managing director of Nielsen China. "Instead of looking at just that last click before purchase, the Nielsen-JD.com MTA offering allows us to track the full online shopping path and then leverage the most effective touch points for better engagement with the consumer."
Yan Weipeng, vice president of JD.com, said, "Under the common goal of maximising marketing efficiency and sales of manufacturers and brands, JD's collaboration with Nielsen is a win-win solution. MTA promotes a thorough view of the omnichannel environment, while encouraging creative business models to provide door opening advertising services to consumers. This is the first of many steps in digital marketing that leverages Big Data to help brands focus their investment on the most appropriate factors.”
Looking for chemical products? Let suppliers reach out to you!
2026-07-13
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Nielsen: The food consumer market will be permanently changed by the epidemic
-
ICIS Global No.58: ECHEMI Again Ranks Among the World’s Chemical Distributors
-
Address Change Declaration(ECHEMI SPECIALTIES)
-
International Workers' Day Holiday Notice and Service Arrangement
-
Supporting Each Other | ECHEMI Employees Voluntarily Raise Funds for Flood Relief in Southern Thailand
-
New Location, New Horizon: ECHEMI Thailand Branch Embarks on a New Chapter
-
Notice of 2026 Chinese New Year Holiday
-
China’s API Export Shift Takes Center Stage at API China 2026
Recommend Reading
-
Ineos Invests £30m to Reduce Emissions at Hull Site by 75%
-
December’s Coking Coal Market Primarily Exhibits Weak Performance
-
Sekisui Specialty Chemicals Has Announced a Global Price Increase
-
India Extends Anti-Dumping Duties on Aniline Imports from China for Five More Years
-
Sanofi’s $2.2 Billion Dynavax Acquisition: Why Big Pharma Is Rebuilding the Global Vaccine Order